{"id":"https://openalex.org/W4406065835","doi":"https://doi.org/10.1016/s0022-3565(24)36376-1","title":"Pharmacological Characterization of Recombinant Human Neuronal Nicotinic Acetylcholine Receptors h\u03b12\u03b22, h\u03b12\u03b24, h\u03b13\u03b22, h\u03b13\u03b24, h\u03b14\u03b22, h\u03b14\u03b24 and h\u03b17 Expressed in Xenopus Oocytes","display_name":"Pharmacological Characterization of Recombinant Human Neuronal Nicotinic Acetylcholine Receptors h\u03b12\u03b22, h\u03b12\u03b24, h\u03b13\u03b22, h\u03b13\u03b24, h\u03b14\u03b22, h\u03b14\u03b24 and h\u03b17 Expressed in Xenopus Oocytes","publication_year":1997,"publication_date":"1997-01-01","ids":{"openalex":"https://openalex.org/W4406065835","doi":"https://doi.org/10.1016/s0022-3565(24)36376-1","mag":"2301755841","pmid":"https://pubmed.ncbi.nlm.nih.gov/8996215"},"language":"en","primary_location":{"id":"doi:10.1016/s0022-3565(24)36376-1","doi":"https://doi.org/10.1016/s0022-3565(24)36376-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0022-3565(24)36376-1","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058338570","display_name":"Laura E. Chavez-Noriega","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Laura E. Chavez-Noriega","raw_affiliation_strings":["SIBIA Neurosciences, Inc., La Jolla, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SIBIA Neurosciences, Inc., La Jolla, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018684053","display_name":"James H. Crona","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James H. Crona","raw_affiliation_strings":["SIBIA Neurosciences, Inc., La Jolla, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SIBIA Neurosciences, Inc., La Jolla, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108499702","display_name":"Mark S. Washburn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark S. Washburn","raw_affiliation_strings":["SIBIA Neurosciences, Inc., La Jolla, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SIBIA Neurosciences, Inc., La Jolla, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019939646","display_name":"Arturo Urrutia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arturo Urrutia","raw_affiliation_strings":["SIBIA Neurosciences, Inc., La Jolla, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SIBIA Neurosciences, Inc., La Jolla, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061622704","display_name":"Kathryn J. Elliott","orcid":"https://orcid.org/0000-0002-4926-1215","observed_orcids":["https://orcid.org/0000-0002-4926-1215"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathryn J. Elliott","raw_affiliation_strings":["SIBIA Neurosciences, Inc., La Jolla, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SIBIA Neurosciences, Inc., La Jolla, California","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037550880","display_name":"Edwin C. Johnson","orcid":"https://orcid.org/0000-0002-0092-1008","observed_orcids":["https://orcid.org/0000-0002-0092-1008"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edwin C. Johnson","raw_affiliation_strings":["SIBIA Neurosciences, Inc., La Jolla, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SIBIA Neurosciences, Inc., La Jolla, California","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5058338570"],"corresponding_institution_ids":[],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":6.0527,"has_fulltext":false,"cited_by_count":406,"citation_normalized_percentile":{"value":0.97614576,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"280","issue":"1","first_page":"346","last_page":"356"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuronal-nicotinic-acetylcholine-receptors","display_name":"neuronal nicotinic acetylcholine receptors","score":0.9570000171661377},{"id":"https://openalex.org/keywords/nicotinic-agonists","display_name":"nicotinic agonists","score":0.718999981880188},{"id":"https://openalex.org/keywords/acetylcholine","display_name":"acetylcholine","score":0.9309999942779541},{"id":"https://openalex.org/keywords/nicotine","display_name":"nicotine","score":0.9589999914169312},{"id":"https://openalex.org/keywords/cytisine","display_name":"cytisine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/dmpp","display_name":"DMPP","score":0.9319999814033508},{"id":"https://openalex.org/keywords/nicotinic-receptor-antagonists","display_name":"nicotinic antagonists","score":0.8550000190734863},{"id":"https://openalex.org/keywords/mecamylamine","display_name":"mecamylamine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/tubocurarine","display_name":"tubocurarine","score":0.8880000114440918},{"id":"https://openalex.org/keywords/dihydro-beta-erythroidine","display_name":"dihydro-beta-erythroidine","score":0.9869999885559082},{"id":"https://openalex.org/keywords/agonist-potency","display_name":"agonist potency","score":0.5550000071525574},{"id":"https://openalex.org/keywords/receptor-subunit-composition","display_name":"receptor subunit composition","score":0.5519999861717224}],"concepts":[{"id":"https://openalex.org/C188987157","wikidata":"https://www.wikidata.org/wiki/Q7030581","display_name":"Nicotinic agonist","level":3,"score":0.7268383502960205},{"id":"https://openalex.org/C80161118","wikidata":"https://www.wikidata.org/wiki/Q408520","display_name":"Acetylcholine receptor","level":3,"score":0.6614653468132019},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.6410877704620361},{"id":"https://openalex.org/C2775910092","wikidata":"https://www.wikidata.org/wiki/Q180623","display_name":"Acetylcholine","level":2,"score":0.6080880165100098},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5702698826789856},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5227541923522949},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5089693069458008},{"id":"https://openalex.org/C51927110","wikidata":"https://www.wikidata.org/wiki/Q4734895","display_name":"Alpha-4 beta-2 nicotinic receptor","level":5,"score":0.4732804000377655},{"id":"https://openalex.org/C2779570518","wikidata":"https://www.wikidata.org/wiki/Q412256","display_name":"Nicotinic acetylcholine receptor","level":4,"score":0.41941037774086},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24584171175956726},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24445107579231262},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009865","descriptor_name":"Oocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014982","descriptor_name":"Xenopus laevis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018733","descriptor_name":"Nicotinic Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0022-3565(24)36376-1","doi":"https://doi.org/10.1016/s0022-3565(24)36376-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0022-3565(24)36376-1","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},{"id":"pmid:8996215","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8996215","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacology and experimental therapeutics","raw_type":"Journal Article"},{"id":"mag:2301755841","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8996215","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":56,"referenced_works":["https://openalex.org/W129138400","https://openalex.org/W138676517","https://openalex.org/W1531561158","https://openalex.org/W1799536240","https://openalex.org/W1804009526","https://openalex.org/W1886298596","https://openalex.org/W1900806927","https://openalex.org/W1969769755","https://openalex.org/W1971009901","https://openalex.org/W1972833869","https://openalex.org/W1973402512","https://openalex.org/W1978224954","https://openalex.org/W1981572398","https://openalex.org/W1986445622","https://openalex.org/W1989901068","https://openalex.org/W2007226311","https://openalex.org/W2010199408","https://openalex.org/W2015290558","https://openalex.org/W2024338604","https://openalex.org/W2027203216","https://openalex.org/W2028052643","https://openalex.org/W2030652929","https://openalex.org/W2037097116","https://openalex.org/W2037174026","https://openalex.org/W2038995429","https://openalex.org/W2039304790","https://openalex.org/W2045348184","https://openalex.org/W2046265755","https://openalex.org/W2047547642","https://openalex.org/W2049722290","https://openalex.org/W2049949416","https://openalex.org/W2054668681","https://openalex.org/W2061569848","https://openalex.org/W2061675635","https://openalex.org/W2069317157","https://openalex.org/W2070295245","https://openalex.org/W2071575489","https://openalex.org/W2083621243","https://openalex.org/W2086808366","https://openalex.org/W2087062737","https://openalex.org/W2090815384","https://openalex.org/W2091821037","https://openalex.org/W2092210494","https://openalex.org/W2093932843","https://openalex.org/W2099542365","https://openalex.org/W2109223175","https://openalex.org/W2127618759","https://openalex.org/W2131859094","https://openalex.org/W2142283506","https://openalex.org/W2157765963","https://openalex.org/W2174802300","https://openalex.org/W2238918217","https://openalex.org/W2341466301","https://openalex.org/W2342322127","https://openalex.org/W2411900406","https://openalex.org/W4319053089"],"related_works":["https://openalex.org/W2301755841","https://openalex.org/W1799536240","https://openalex.org/W129138400","https://openalex.org/W2039975064","https://openalex.org/W3199969049","https://openalex.org/W2050917293","https://openalex.org/W7220894188","https://openalex.org/W2148168931","https://openalex.org/W7100434515","https://openalex.org/W138676517"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":15},{"year":2013,"cited_by_count":17},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2025-01-05T00:00:00"}